Your browser doesn't support javascript.
loading
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
Schettini, Francesco; Chic, Nuria; Brasó-Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez-Sáez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernández-Martinez, Aranzazu; González-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Peg, Vicente; Fasani, Roberta; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H; Lluch, Ana; Martín, Miguel; Locci, Mariavittoria; De Placido, Sabino; Prat, Aleix.
Afiliação
  • Schettini F; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Chic N; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Brasó-Maristany F; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Pascual T; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Conte B; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Martínez-Sáez O; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Adamo B; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Vidal M; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Barnadas E; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Fernández-Martinez A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • González-Farre B; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Sanfeliu E; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
  • Cejalvo JM; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Perrone G; Department of Medical Oncology, Ospedale Policlinico San Martino, University of Genova, Genova, Italy.
  • Sabarese G; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Zalfa F; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Peg V; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Fasani R; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Villagrasa P; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Gavilá J; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Barrios CH; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Lluch A; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
  • Martín M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Locci M; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
  • De Placido S; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
  • Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
NPJ Breast Cancer ; 9(1): 32, 2023 Apr 29.
Article em En | MEDLINE | ID: mdl-37120452

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália